Aging and vascular dysfunction: Beneficial melatonin effects

Age

Volumn 35, Issue 1, 2013, Pages 103-115

  Rodella, Luigi Fabrizio ^a   Favero, Gaia ^a   Rossini, Claudia ^a   Foglio, Eleonora ^a   Bonomini, Francesca ^a   Reiter, Russel J ^b   Rezzani, Rita ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Aging; Atherosclerosis; Endothelial cells; Melatonin

Indexed keywords

APOLIPOPROTEIN E; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; MELATONIN; PROTEIN P53; SIRTUIN 1;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG FORMULATION; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; LOW DRUG DOSE; MORPHOLOGY; MOUSE; NONHUMAN; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

AGING; ANIMALS; ANTIOXIDANTS; ATHEROSCLEROSIS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; MALE; MELATONIN; MICE; MICE, INBRED C57BL; OXIDATIVE STRESS; RADIOIMMUNOASSAY; UP-REGULATION; VASODILATION;

EID: 84872596242     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-011-9336-z     Document Type: Article

References (67)

1. An SJ, Boyd R, Wang Y, Qiu X, Wang HD (2006) Endothelin-1 expression in vascular adventitial fibroblasts. Am J Physiol Heart Circ Physiol 290(2):H700-H708
2. Arunachalam G, Yao H, Sundar IK, Caito S, Rahman I (2010) SIRT1 regulates oxidant-and cigarette smoke-induced eNOS acetylation in endothelial cells: role of resveratrol. Biochem Biophys Res Commun 393(1):66-72
3. Balaban RS, Nemoto S, Finkel T (2005) Mitochondria, oxidants, and aging. Cell 120(4):483-495
4. Baur JA (2010) Biochemical effects of SIRT1 activators. Biochim Biophys Acta 1804(8):1626-1634
5. Benot S, Goberna R, Reiter RJ, Garcia-Mauriño S, Osuna C, Guerrero JM (1999) Physiological levels of melatonin contribute to the antioxidant capacity of human serum. J Pineal Res 27(1):59-64
6. Borradaile NM, Pickering JG (2010) Polyploidy impairs human aortic endothelial cell function and is prevented by nicotinamide phosphoribosyltransferase. Am J Physiol Cell Physiol 298(1):C66-C74
7. Bubenik GA, Konturek SJ (2011) Melatonin and aging: prospects for human treatment. J Physiol Pharmacol 62(1):13-19
8. Chang HM, Wu UI, Lan CT (2009) Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res 47(3):211-220
9. Chen Z, Peng IC, Cui X, Li YS, Chien S, Shyy JY (2010) Shear stress, SIRT1, and vascular homeostasis. Proc Natl Acad Sci USA 107(22):10268-10273
10. Chung S, Yao H, Caito S, Hwang JW, Arunachalam G, Rahman I (2010) Regulation of SIRT1 in cellular functions: role of polyphenols. Arch Biochem Biophys 501(1):79-90
11. Coleman R, Hayek T, Keidar S, Aviram M (2006) A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochem 108(6):415-424
12. Danz ED, Skramsted J, Henry N, Bennett JA, Keller RS (2009) Resveratrol prevents doxorubicin cardiotoxicity through mitochondrial stabilization and the Sirt1 pathway. Free Radic Biol Med 46(12):1589-1597
13. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285-1295
14. Di Wang H, Rätsep MT, Chapman A, Boyd R (2010) Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond. Can J Physiol Pharmacol 88(3):177-186
15. Dominguez-Rodriguez A, Abreu-Gonzalez P, Sanchez-Sanchez JJ, Kaski JC, Reiter RJ (2010) Melatonin and circadian biology in human cardiovascular disease. J Pineal Res 49(1):14-22
16. Donmez G, Guarente L (2010) Aging and disease: connections to sirtuins. Aging Cell 9(2):285-290
17. Ergul A (2011) Endothelin-1 and diabetic complications: focus on the vasculature. Pharmacol Res 63(6):477-482
18. Guarani V, Potente M (2010) SIRT1 - a metabolic sensor that controls blood vessel growth. Curr Opin Pharmacol 10(2):139-145
19. Gutierrez-Cuesta J, Tajes M, Jiménez A, Coto-Montes A, Camins A, Pallàs M (2008) Evaluation of potential pro-survival pathways regulated by melatonin in a murine senescence model. J Pineal Res 45(4):497-505
20. Han MK, Song EK, Guo Y, Ou X, Mantel C, Broxmeyer HE (2008) SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell 2(3):241-251
21. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T (2003) Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 108(4):500
22. Higashi Y, Noma K, Yoshizumi M, Kihara Y (2009) Endothelial function and oxidative stress in cardiovascular diseases. Circ J 73(3):411-418
23. Inanaga K, Ichiki T, Miyazaki R, Takeda K, Hashimoto T, Matsuura H, Sunagawa K (2010) Acetylcholinesterase inhibitors attenuate atherogenesis in apolipoprotein E-knockout mice. Atherosclerosis 213(1):52-58
24. Ito T, Yagi S, Yamakuchi M (2010) MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 398(4):735-740
25. Ivey ME, Osman N, Little PJ (2008) Endothelin-1 signalling in vascular smooth muscle: pathways controlling cellular functions associated with atherosclerosis. Atherosclerosis 199(2):237-247
26. Jawien J, Nastalek P, Korbut R (2004) Mouse models of experimental atherosclerosis. J Physiol Pharmacol 55:503-517
27. Jung-Hynes B, Ahmad N (2009) SIRT1 controls circadian clock circuitry and promotes cell survival: a connection with age-related neoplasms. FASEB J 23(12):4370
28. Jung-Hynes B, Reiter RJ, Ahmad N (2010) Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res 48(1):9-19
29. Kalani M (2008) The importance of endothelin-1 for microvascular dysfunction in diabetes. Vasc Health Risk Manag 4(5):1061-1068
30. Kato R, Mori C, Kitazato K, Arata S, Obama T, Mori M, Takahashi K, Aiuchi T, Takano T, Itabe H (2009) Transient increase in plasma oxidized LDL during the progression of atherosclerosis in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 29(1):33-39
31. Köhler R, Hoyer J (2007) Role of TRPV4 in the mechanotransduction of shear stress in endothelial cells. In: Liedtke WB, Heller S (eds) TRP ion channel function in sensory transduction and cellular signalling cascades. CRC Press, Boca Raton, Chapter 27
32. Li L, Gao P, Zhang H, Chen H, Zheng W, Lv X, Xu T, Wei Y, Liu D, Liang C (2011) SIRT1 inhibits angiotensin II-induced vascular smooth muscle cell hypertrophy. Acta Biochim Biophys Sin (Shanghai) 43(2):103-109
33. Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, DeRicco J, Kasuno K, Irani K (2007) SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci USA 104(37):14855-14860
34. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R (1994) ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 14(1):133-140
35. Ota H, Akishita M, Eto M, Iijima K, Kaneki M, Ouchi Y (2007) Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol 43(5):571-579
36. Ota H, Eto M, Kano MR, Ogawa S, Iijima K, Akishita M, Ouchi Y (2008) Cilostazol inhibits oxidative stress-induced premature senescence via upregulation of Sirt1 in human endothelial cells. Arterioscler Thromb Vasc Biol 28(9):1634-1639
37. Ota H, Eto M, Ogawa S, Iijima K, Akishita M, Ouchi Y (2010) SIRT1/eNOS axis as a potential target against vascular senescence, dysfunction and atherosclerosis. J Atheroscler Thromb 17(5):431-435
38. Pallas M, Junyet F, Verdaguer E, Beas-Zarate, Camins (2011) Aging control with resveratrol. Aging Drug Discov Today 7(3-4):51-56
39. Pallàs M, Pizarro JG, Gutierrez-Cuesta J, Crespo-Biel N, Alvira D, Tajes M, Yeste-Velasco M, Folch J, Canudas AM, Sureda FX, Ferrer I, Camins A (2008) Modulation of SIRT1 expression in different neurodegenerative models and human pathologies. Neuroscience 154(4):1388-1397
40. Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM (2010) Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 48(4):297-310
41. Paredes SD, Bejarano I, Terrón MP, Barriga C, Reiter RJ, Rodríguez AB (2009) Melatonin and tryptophan counteract lipid peroxidation and modulate superoxide dismutase activity in ringdove heterophils in vivo. Effect of antigen-induced activation and age. Age (Dordr) 31(3):179-188
42. Pereira TM, Nogueira BV, Lima LC, Porto ML, Arruda JA, Vasquez EC, Meyrelles SS (2010) Cardiac and vascular changes in elderly atherosclerotic mice: the influence of gender. Lipids Health Dis 9:87
43. Poeggeler B (2005) Melatonin, aging, and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 27(2):201-212
44. Reiter RJ (1992) The ageing pineal gland and its physiological consequences. Bioessays 14(3):169-175
45. Reiter RJ, Tan DX, Mayo JC, Sainz RM, Lopez-Burillo S (2002) Melatonin, longevity and health in the aged: an assessment. Free Radic Res 36(12):1323-1329
46. Reiter RJ, Paredes SD, Manchester LC, Tan DX (2009) Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin. Crit Rev Biochem Mol Biol 44(4):175-200
47. Reiter RJ, Tan DX, Fuentes-Broto L (2010a) Melatonin: a multitasking molecule. Prog Brain Res 181:127-151
48. Reiter RJ, Tan DX, Paredes SD, Fuentes-Broto L (2010b) Beneficial effects of melatonin in cardiovascular disease. Ann Med 42(4):276-285
49. Riley T, Sontag E, Chen P, Levine A (2008) Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9(5):402-412
50. Rippe C, Lesniewski L, Connell M, LaRocca T, Donato A, Seals D (2010) Short-term calorie restriction reverses vascular endothelial dysfunction in old mice by increasing nitric oxide and reducing oxidative stress. Aging Cell 9(3):304-312
51. Rodella LF, Bonomini F, Rezzani R, Tengattini S, Hayek T, Aviram M, Keidar S, Coleman R, Bianchi R (2007) Atherosclerosis and the protective role played by different proteins in apolipoprotein E-deficient mice. Acta Histochem 109(1):45-51
52. Rodella LF, Favero G, Rossini C, Foglio E, Reiter RJ, Rezzani R (2010) Endothelin-1 as a potential marker of melatonin's therapeutic effects in smoking-induced vasculopathy. Life Sci 87(17-18):558-564
53. Schiffrin EL (2004) Remodeling of resistance arteries in essential hypertension and effects of antihypertensive treatment. Am J Hypertens 17(12 Pt 1):1192-1200
54. Song G, Liu J, Zhao Z, Yu Y, Tian H, Yao S, Li G, Qin S (2011) Simvastatin reduces atherogenesis and promotes the expression of hepatic genes associated with reverse cholesterol transport in apoE-knockout mice fed high-fat diet. Lipids Health Dis 10:8
55. Stein S, Lohmann C, Handschin C, Stenfeldt E, Borén J, Lüscher TF, Matter CM (2010) ApoE-/- PGC-1α-/- mice display reduced IL-18 levels and do not develop enhanced atherosclerosis. PLoS One 5(10):e13539
56. Tajes M, Gutierrez-Cuesta J, Ortuño-Sahagun D, Camins A, Pallàs M (2009) Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway. J Pineal Res 47(3):228-237
57. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1:57-60
58. Tang BL (2011) Sirt1's systemic protective roles and its promise as a target in antiaging medicine. Transl Res 157(5):276-284
59. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA (2001) hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107(2):149-159
60. Wang M, Khazan B, Lakatta EG (2010) Central arterial aging and angiotensin II signaling. Curr Hypertens Rev 6(4):266-281
61. Welp A, Manz B, Peschke E (2010) Development and validation of a high throughput direct radioimmunoassay for the quantitative determination of serum and plasma melatonin (N-acetyl-5-methoxytryptamine) in mice. J Immunol Methods 358(1-2):1-8
62. Yang NC, Song TY, Chen MY, Hu ML (2011) Effects of 2-deoxyglucose and dehydroepiandrosterone on intracellular NAD(+) level, SIRT1 activity and replicative lifespan of human Hs68 cells. Biogerontology 12(64):527-536
63. Yatera Y, Shibata K, Furuno Y, Sabanai K, Morisada N, Nakata S, Morishita T, Toyohira Y, Wang KY, Tanimoto A, Sasaguri Y, Tasaki H, Nakashima Y, Shimokawa H, Yanagihara N, Otsuji Y, Tsutsui M (2010) Severe dyslipidaemia, atherosclerosis, and sudden cardiac death in mice lacking all NO synthases fed a high-fat diet. Cardiovasc Res 87(4):675-682
64. Yu W, Fu YC, Chen CJ, Wang X, Wang W (2009) SIRT1: a novel target to prevent atherosclerosis. J Cell Biochem 108(1):10-13
65. Zhang WJ, Bird KE, McMillen TS, LeBoeuf RC, Hagen TM, Frei B (2008) Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice. Circulation 117(3):421-428
66. Zhao R, Domann FE, Zhong W (2006) Apoptosis induced by selenomethionine and methioninase is superoxide mediated and p53 dependent in human prostate cancer cells. Mol Cancer Ther 5(12):3275-3284
67. Zu Y, Liu L, Lee MY, Xu C, Liang Y, Man RY, Vanhoutte PM, Wang Y (2010) SIRT1 promotes proliferation and prevents senescence through targeting LKB1 in primary porcine aortic endothelial cells. Circ Res 106(8):1384-1393